logo
logo

BayPine to acquire CenExel for $1.5 billion

Apr 12, 2025•4 months ago

Acquiring Company

BayPine

Acquired Company

CenExel Clinical Research

BostonSalt Lake CityFinancial ServicesHealth Care

Description

BayPine has reached a deal to acquire CenExel Clinical Research for approximately $1.5 billion. This acquisition reflects ongoing deal-making activity in uncertain financial markets. CenExel is valued based on its earnings before interest, taxes, depreciation, and amortization. The acquisition indicates BayPine's strategy to enhance its investment portfolio.

Company Information

Company

BayPine

Location

Boston, Massachusetts, United States

About

BayPine is a private investment firm that seeks to create lasting value for the firm's investors, portfolio companies and communities in which they operate by driving innovation, digital transformation and sustainable growth in market-leading businesses across traditional sectors of the economy. Headquartered in Boston, BayPine was founded by a team of accomplished investors and senior executives who have a shared passion for building enduring companies. For more information about BayPine, please visit www.baypine.com.

Related People

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed